- A Comparative Study on Comorbidity Measurements with Lookback Period using Health Insurance Database: Focused on Patients Who Underwent Percutaneous Coronary Intervention.
-
Kyoung Hoon Kim, Lee Su Ahn
-
J Prev Med Public Health. 2009;42(4):267-273.
-
DOI: https://doi.org/10.3961/jpmph.2009.42.4.267
-
-
5,561
View
-
109
Download
-
13
Crossref
-
Abstract
PDF
- OBJECTIVES
To compare the performance of three comorbidity measurements (Charlson comorbidity index, Elixhauser's comorbidity and comorbidity selection) with the effect of different comorbidity lookback periods when predicting in-hospital mortality for patients who underwent percutaneous coronary intervention. METHODS: This was a retrospective study on patients aged 40 years and older who underwent percutaneous coronary intervention. To distinguish comorbidity from complications, the records of diagnosis were drawn from the National Health Insurance Database excluding diagnosis that admitted to the hospital. C-statistic values were used as measures for in comparing the predictability of comorbidity measures with lookback period, and a bootstrapping procedure with 1,000 replications was done to determine approximate 95% confidence interval. RESULTS: Of the 61,815 patients included in this study, the mean age was 63.3 years (standard deviation: +/-10.2) and 64.8% of the population was male. Among them, 1,598 (2.6%) had died in hospital. While the predictive ability of the Elixhauser s comorbidity and comorbidity selection was better than that of the Charlson comorbidity index, there was no significant difference among the three comorbidity measurements. Although the prevalence of comorbidity increased in 3 years of lookback periods, there was no significant improvement compared to 1 year of a lookback period. CONCLUSIONS: In a health outcome study for patients who underwent percutaneous coronary intervention using National Health Insurance Database, the Charlson comorbidity index was easy to apply without significant difference in predictability compared to the other methods. The one year of observation period was adequate to adjust the comorbidity. Further work to select adequate comorbidity measurements and lookback periods on other diseases and procedures are needed.
-
Summary
-
Citations
Citations to this article as recorded by
- Adjusting for Confounders in Outcome Studies Using the Korea National Health Insurance Claim Database: A Review of Methods and Applications
Seung Jin Han, Kyoung Hoon Kim Journal of Preventive Medicine and Public Health.2024; 57(1): 1. CrossRef - High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study
Sungho Bea, In‐Sun Oh, Ju Hwan Kim, Dong Hyun Sinn, Yoosoo Chang, Seungho Ryu, Ju‐Young Shin Journal of the American Heart Association.2023;[Epub] CrossRef - Impact of comorbidity assessment methods to predict non-cancer mortality risk in cancer patients: a retrospective observational study using the National Health Insurance Service claims-based data in Korea
Sanghee Lee, Yoon Jung Chang, Hyunsoon Cho BMC Medical Research Methodology.2021;[Epub] CrossRef - Evaluating the impact of covariate lookback times on performance of patient-level prediction models
Jill Hardin, Jenna M. Reps BMC Medical Research Methodology.2021;[Epub] CrossRef - Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012)
Abbey Diaz, Peter D. Baade, Patricia C. Valery, Lisa J. Whop, Suzanne P. Moore, Joan Cunningham, Gail Garvey, Julia M. L. Brotherton, Dianne L. O’Connell, Karen Canfell, Diana Sarfati, David Roder, Elizabeth Buckley, John R. Condon, Stéphanie Filleur PLOS ONE.2018; 13(5): e0196764. CrossRef - Comorbidity Adjustment in Health Insurance Claim Database
Kyoung Hoon Kim Health Policy and Management.2016; 26(1): 71. CrossRef - The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access
Lorenzo Azzalini, Kunle Tosin, Malorie Chabot-Blanchet, Robert Avram, Hung Q. Ly, Benoit Gaudet, Richard Gallo, Serge Doucet, Jean-François Tanguay, Réda Ibrahim, Jean C. Grégoire, Jacques Crépeau, Raoul Bonan, Pierre de Guise, Mohamed Nosair, Jean-Franço JACC: Cardiovascular Interventions.2015; 8(14): 1854. CrossRef - A Convergence Study in the Severity-adjusted Mortality Ratio on inpatients with multiple chronic conditions
Young-Suk Seo, Sung-Hong Kang Journal of Digital Convergence.2015; 13(12): 245. CrossRef - Development and validation of comorbidity index in South Korea
S.-R. Kil, S.-I. Lee, Y.-H. Khang, M.-S. Lee, H.-J. Kim, S.-O. Kim, M.-W. Jo International Journal for Quality in Health Care.2012; 24(4): 391. CrossRef - Development of Mortality Model of Severity-Adjustment Method of AMI Patients
Ji-Hye Lim, Mun-Hee Nam Journal of the Korea Academia-Industrial cooperation Society.2012; 13(6): 2672. CrossRef - Use of hospitalisation history (lookback) to determine prevalence of chronic diseases: impact on modelling of risk factors for haemorrhage in pregnancy
Jian Sheng Chen, Christine L Roberts, Judy M Simpson, Jane B Ford BMC Medical Research Methodology.2011;[Epub] CrossRef - The Impact of Medicaid Expansion to include population with low income on the preventable hospitalizations
Hyun-Chul Shin, Se-Ra Kim Korean Journal of Health Policy and Administration.2010; 20(1): 87. CrossRef - Comparative Study on Three Algorithms of the ICD-10 Charlson Comorbidity Index with Myocardial Infarction Patients
Kyoung Hoon Kim Journal of Preventive Medicine and Public Health.2010; 43(1): 42. CrossRef
|